Rhenovia signs an R&D contract with Sodiaal-Candia for studying the nutritional and therapeutic value of milk and its derivatives

28-Apr-2011 - France

Rhenovia Pharma SAS announced the signing of a research-and-development contract with Sodiaal-Candia. The contract is aimed at identifying new avenues of research for better understanding the beneficial effects on human health of the milk components and its derivatives. The research will focus in particular on studying their nutritional and therapeutic value. The financial terms of the deal were not disclosed.

This contract will enable Rhenovia to expand the application of its technology from medical products to food markets, and Sodiaal to better understand the effects of food on human health, and especially on people’s predisposition to neurodegenerative diseases, for the best benefit of consumers. Analyzing the links between nutrition and health is very difficult at the experimental and conceptual level. The methods of pharmaceutical research are required to understand the mechanisms of action of bioactive nutritional components. This is the core activity of Rhenovia, which will apply its know-how to identify the potential molecular or physiological targets of milk and its components. Results of these studies will improve our understanding of the relationships between food, health and predisposition to degenerative diseases.

The research project will draw on Rhenovia’s technical expertise, especially its biosimulation platform for pathologies of the central and peripheral nervous systems, for studying the influence of food on human health, and importantly on the development of neurodegenerative diseases and age-related pathologies. Poor eating habits are a major risk factor that can facilitate the development of diseases, especially cardiovascular pathologies, cancer and neurodegenerative diseases. A healthy, balanced and rationally adapted diet might not only delay the emergence of these diseases and slow their progression, but also correct or enhance the efficacy of medicinal treatments and/or reduce their side-effects.

https://www.bionity.com/en/news/132129/rhenovia-signs-an-r-d-contract-with-sodiaal-candia-for-studying-the-nutritional-and-therapeutic-value-of-milk-and-its-derivatives.html